IL6 and systemic inflammatory response syndrome: Via immune activation, DAMPs trigger a systemic inflammatory response syndrome (SIRS) that is characterised in part by elevated circulating concentrations of a range of pro-inflammatory cytokines (Interleukin IL6, Tumor Necrosis Factor α) [8, 9].